On back of attending ChannelAdvisor’s Catalyst 2017 annual user conference in Nasvhille on March 7th and 8th, William Blair analyst Ryan Domyancic has …
Synthetic Biologics Inc (NYSEMKT:SYN) is steaming right along with key programs gearing toward pivotal studies. Despite financing continuing to be the real stand-out …
Aratana Therapeutics Inc (NASDAQ:PETX) shares were falling nearly 18% on the heels of Friday’s announcement revealing that Entyce, approved in the U.S.
William Blair analysts are commending Facebook Inc (NASDAQ:FB) and Apple Inc. (NASDAQ:AAPL) after these two stock giants roared into a new earnings season …
William Blair analyst Ralph Schackart is out with a research report on Netflix, Inc. (NASDAQ:NFLX) underscoring how the video streaming giant’s original content …
As he previews fourth-quarter results for these two biotech giants, William Blair analyst John Sonnier is setting positive expectations on Gilead Sciences, Inc. (NASDAQ:GILD) …
Synthetic Biologics Inc (NYSEMKT:SYN) revealed Wednesday, January 18th after market close that the FDA has green-lighted its Phase IIb/III adaptive trial design of …
William Blair analyst Ralph Schackart offers a bullish take on Netflix, Inc. (NASDAQ:NFLX) after adding the online streaming giant’s addition to the 246th Current …
Yesterday morning, Amazon.com, Inc.
Achaogen Inc (NASDAQ:AKAO) shares rose 14% today after the company reported positive top-line results from the phase 3 trial of its treatment for urinary …
